Successful macular hole surgery

Article

Fixation stability influences the visual outcome following macular hole surgery, according to study results published in the January issue of Investigative Ophthalmology and Visual Science.

Fixation stability influences the visual outcome following macular hole surgery, according to study results published in the January issue of Investigative Ophthalmology and Visual Science.

Luminita Tarita-Nistor of Toronto Western Hopital and York University, Toronto, Canada and colleagues measured the visual acuity of patients (n=10) before and one and three months after surgery to correct macular hole. The researchers measured fixation stability and fixation location using the MP-1 Microperimeter (Nidek Technologies Srl), and quantified the degree of stability and amount of location shift.

Following surgery, the fixation location shifted a mean of 0.55º at one month and 0.87º at three months. This did not correlate with visual outcome. The fixation stability, however - which improved from 0.35º2 at one month to 0.29º2 at three months - was a good predictor of visual outcome.

The researchers concluded that the improvements in motor function following macular hole closure accounts for the improvement in visual function, and that a change in the stability of the fixation predicts the degree of visual improvement after this type of surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.